A novel mouse model for obesity, type 2 diabetes, and nonalcoholic fatty liver disease

被引：0
|
作者：
Dhar, M
Sommardahl, C
Castellani, L
Johnson, D
机构：
来源：
OBESITY RESEARCH | 2003年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A5 / A5
页数：1
相关论文
共 50 条
  • [41] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Xueyang Zhang
    Ran Bai
    Yong Jia
    Junwei Zong
    Yongbo Wang
    Yanan Dong
    International Journal of Diabetes in Developing Countries, 2020, 40 : 491 - 499
  • [42] Type 2 Diabetes, Congestive Heart Failure, and Nonalcoholic Fatty Liver Disease
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Sprenger, Lukas
    Leiherer, Andreas
    Purin, Daniela
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2020, 69
  • [43] Nonalcoholic Fatty Liver Disease The New Complication of Type 2 Diabetes Mellitus
    Bril, Fernando
    Cusi, Kenneth
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2016, 45 (04) : 765 - +
  • [44] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
    Saponaro, Chiara
    Gaggini, Melania
    Gastaldelli, Amalia
    CURRENT DIABETES REPORTS, 2015, 15 (06) : 1 - 13
  • [45] Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease
    Newton, Kimberly P.
    Hou, Jiayi
    Crimmins, Nancy A.
    Lavine, Joel E.
    Barlow, Sarah E.
    Xanthakos, Stavra A.
    Africa, Jonathan
    Behling, Cynthia
    Donithan, Michele
    Clark, Jeanne M.
    Schwimmer, Jeffrey B.
    JAMA PEDIATRICS, 2016, 170 (10)
  • [46] Nonalcoholic fatty liver disease and the risk of type 2 diabetes in the United States
    Clark, JM
    Diehl, AM
    Brancati, FL
    DIABETES, 2001, 50 : A38 - A39
  • [47] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
    Ismail, Mona H.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (06): : 485 - 492
  • [48] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Zhang, Xueyang
    Bai, Ran
    Jia, Yong
    Zong, Junwei
    Wang, Yongbo
    Dong, Yanan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2020, 40 (04) : 491 - 499
  • [49] Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models
    Matsukawa, Toshiya
    Yagi, Takashi
    Uchida, Tohru
    Sakai, Mashito
    Mitsushima, Masaru
    Naganuma, Takao
    Yano, Hiroyuki
    Inaba, Yuka
    Inoue, Hiroshi
    Yanagida, Keisuke
    Uematsu, Masaaki
    Nakao, Kazuki
    Nakao, Harumi
    Aiba, Atsu
    Nagashima, Yoji
    Kubota, Tetsuya
    Kubota, Naoto
    Izumida, Yoshihiko
    Yahagi, Naoya
    Unoki-Kubota, Hiroyuki
    Kaburagi, Yasushi
    Asahara, Shun-ichiro
    Kido, Yoshiaki
    Shindou, Hideo
    Itoh, Michiko
    Ogawa, Yoshihiro
    Minami, Shiro
    Terauchi, Yasuo
    Tobe, Kazuyuki
    Ueki, Kohjiro
    Kasuga, Masato
    Matsumoto, Michihiro
    JCI INSIGHT, 2023, 8 (17)
  • [50] Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease
    Raschi, Emanuel
    Mazzotti, Arianna
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Marchesini, Giulio
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) : 1903 - 1914
12345